Living Well with Lung Cancer
| ISRCTN | ISRCTN30820196 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN30820196 |
| Protocol serial number | 6073; MRC G0601695 |
| Sponsor | University of Manchester (UK) |
| Funder | Medical Research Council (MRC) (UK) (ref: G0601695) |
- Submission date
- 12/05/2010
- Registration date
- 12/05/2010
- Last edited
- 29/03/2022
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Plain English summary of protocol
http://www.cancerhelp.org.uk/trials/a-study-of-follow-up-care-after-treatment-for-lung-cancer
Contact information
Scientific
MRC Research Fellow
School of Nursing, Midwifery and Social Work
The University of Manchester
Jean McFarlane Building
University Place
Oxford Road
Manchester
M13 9PL
United Kingdom
Study information
| Primary study design | Observational |
|---|---|
| Study design | Multicentre observational process of care qualitative study |
| Secondary study design | Case series |
| Study type | Participant information sheet |
| Scientific title | Living well with lung cancer: evaluating the effectiveness of a sustainable model of follow-up care |
| Study objectives | Aims: 1. To develop a sustainable model of follow-up service delivery 2. To determine if the model is potentially beneficial (proof of concept) through an exploratory (feasibility) trial with outcomes focused on quality of life, patient satisfaction and cost effectiveness |
| Ethics approval(s) | South Manchester Research Ethics Committee, 24/06/2009, ref: 09/H1003/72 |
| Health condition(s) or problem(s) studied | Topic: National Cancer Research Network; Subtopic: Lung Cancer; Disease: Lung (small cell), Lung (non-small cell) |
| Intervention | Stage one: developing the intervention - In order to develop a robust evidence based intervention this project is designed using steps of the MRC framework for developing and evaluating complex interventions (MRC 2000/2007). The first stage of this framework is to develop the intervention using primarily qualitative methods, once the intervention has been developed a feasibility trial will be designed. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Quality of life |
| Key secondary outcome measure(s) |
1. Survival |
| Completion date | 30/04/2011 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 100 |
| Total final enrolment | 31 |
| Key inclusion criteria | 1. Completed initial treatment for lung cancer 2. Suitable for nurse-led follow-up (as defined in Stage 1) 3. Physically and psychologically able and willing to complete outcome measures 4. Not taking part in any other clinical trial 5. Age restrictions will not be imposed, both male and female participants will be recruited |
| Key exclusion criteria | Patients with a diagnosis of mesothelioma will be excluded at this stage due to complexities of disease management. |
| Date of first enrolment | 01/11/2009 |
| Date of final enrolment | 30/04/2011 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
M13 9PL
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan | Not provided at time of registration |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Plain English results | 08/01/2014 | 29/03/2022 | No | Yes |
Editorial Notes
E29/03/2022: The following changes have been made:
1. The Cancer Research UK lay results summary has been added.
2. The total final enrolment number has been added.
14/03/2017: No publications found in PubMed, verifying study status with principal investigator
22/02/2011: The anticipated end date for this trial has been updated from 30/12/2010 to 30/04/2011.
